Colon CT with Easier Prep OK for Big Lesions (CME/CE)

(MedPage Today) — Virtual colonoscopy technology that eliminates the need for laxative bowel prep appears similar to the optical method for detecting larger adenomas but seems questionable for smaller lesions, a clinical trial determined.

|

Aspirin May Cut Melanoma Risk (CME/CE)

RALEIGH, N.C. (MedPage Today) — The risk of malignant melanoma declined by more than 20% in women who reported using aspirin, a new analysis of the Women’s Health Initiative showed.

|

Lab Notes: Monkey See, Monkey Do

(MedPage Today) — When a monkey has an itch, another one scratches, dermatologists found, and the Brits may have found a way to stop the bells from ringing in tinnitus sufferers’ ears.

|

PodMed: A Medical News Roundup from John Hopkins (with audio)

(MedPage Today) — This week’s topics include the benefits of probiotics, Millennium villages in Africa, fruits for fruit juice, and infection-related cancers worldwide.

|

Dharamshila Hospital Organized A Live Workshop on Composite Resection with Micro vascular Free Fibular Flap reconstruction

A live workshop on Head and Neck Cancer Surgeries was organized at Dharamshila Hospital And Research Centre (DHRC). Worldwide Head and Neck cancers are sixth most common cancers in men.

|

News: Twitter and RSS New Articles and Journal News Services

Libertas offers a range of free services that help you stay in touch with the latest newly published articles and journal news, including Twitter and RSS feedsRSS feeds are available for all Libertas journals, as well as more than 40 subjec…

|

News: All Papers are Professionally Copy Edited

All papers published in Libertas journals benefit from our professional copy editing service prior to publication.As part of our production quality control process, we check papers for a wide range of deficiencies prior to publication.&nbsp…

|

Sun Safety Still Not Strong Among the Young (CME/CE)

(MedPage Today) — Young adults continue to risk developing skin cancer, despite some improvements in protective behavior, according to two analyses by the National Cancer Institute and the CDC.

|

Revlimid Delays Relapse in Multiple Myeloma (CME/CE)

(MedPage Today) — For patients with multiple myeloma, lenalidomide (Revlimid) maintenance therapy extended the time before relapse, researchers on three clinical trials reported.

|

FDA: Revlimid Linked to Second Cancers

(MedPage Today) — Treatment of multiple myeloma with lenalidomide (Revlimid) as maintenance therapy is associated with an increased risk of second primary cancers, the FDA warned.

|